• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

I-tech

69,10 SEK

-0,72 %

Mindre end 1K følgere

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
-0,72 %
+6,64 %
+39,60 %
+32,38 %
+31,37 %
-29,92 %
+58,12 %
+5,50 %
+180,15 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Læs mere
Markedsværdi
829,05 mio. SEK
Aktieomsætning
970,26 t SEK
Omsætning
168,12 mio.
EBIT %
24,41 %
P/E
24,68
Udbytteafkast, %
1,81 %
Omsætning og EBIT-margin
EPS og udbytte
Finanskalender
21.8
2026

Delårsrapport Q2'26

16.10
2026

Delårsrapport Q3'26

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Selskabsmeddelelse21.5.2026, 15.42

Report from the Annual General Meeting 2026 of i-tech AB (publ)

I-tech
Pressemeddelelse20.5.2026, 12.00

Change to the Board nomination proposal ahead of I‑Tech AB’s Annual General Meeting

I-tech
Eksterne analyser8.5.2026, 06.28

I-tech: 2026 looking better than feared - ABG

* Q1: Organic growth of +7% despite tough comps (vs. ABGSCe -15%) * Customer with financial constraints back to normal order cadence * We raise organic growth ests. for '26e to +25% (+15% previously) Q1 results Q1 sales were much stronger than we expected...

I-tech

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Eksterne analyser7.5.2026, 07.05

I-tech: Significant beat across the PL - ABG

* Sales +27% vs. ABGSCe, EBIT SEK 19m vs. ABGSCe 9.8m * A beat on all line items, despite very tough comps * Gross margin 60% (56% LY), though may soften on raw material prices Much stronger growth than expected Sales came in above expectations at SEK...

I-tech
Selskabsmeddelelse7.5.2026, 06.00

I-Tech AB (publ) (ticker: ITECH) publish the interim report for Q1 2026

I-tech
Eksterne analyser5.5.2026, 10.43

I-tech: Announce extension of Selektope until Dec '26 - ABG

* Approval for Selektope extended again, now until Dec '26 * Ongoing process could not be finalised within timeframe * I-Tech views this as positive; invests in new EOGRT study Approval extended again, until Dec '26 The European Commission and the Standing...

I-tech
Pressemeddelelse5.5.2026, 09.46

EU extends approval for Selektope® until 31 December 2026

I-tech
Selskabsmeddelelse20.4.2026, 06.30

NOTICE TO THE ANNUAL GENERAL MEETING OF I-TECH AB (PUBL)

I-tech
Selskabsmeddelelse17.4.2026, 08.30

I-Tech’s Annual Report 2025 is published

I-tech
Eksterne analyser31.3.2026, 06.20

I-tech: Another growth breather in Q1e - ABG

* Q1e sales 42m (57m), adj. EBIT SEK 9.8m (18m) * Updated FX forecasts, we raise '26e-'28e sales by 4-5% * Trading at '26e-'28e EV/EBIT of 8x-3x Q1 expectations We estimate sales of SEK 42m (57m), -27% y-o-y (-15%% org., -12% FX). I-Tech is facing tough...

I-tech
Selskabsmeddelelse18.3.2026, 12.00

I Tech announces change of Certified Adviser

I-tech
Pressemeddelelse9.2.2026, 09.46

Redeye: I-Tech (Q4 Review): Short-term volatility persists, long-term case intact

I-tech
Eksterne analyser6.2.2026, 06.20

I-tech: A pause in pace, not the story - ABG

* Q4: -23% organic growth (vs. ABGSCe -12%) * Financially constrained customer weighed on ’25 org. growth * Long-term potential intact, expect continued CMP growth in '26e 2025, a mixed financial year Q4 organic growth came in below our estimate at -...

I-tech
Pressemeddelelse5.2.2026, 10.20

Correction: Time for live year-end report presentation

I-tech
Eksterne analyser5.2.2026, 10.06

I-tech: Customer pullback weighing on growth - ABG

Sales -13% vs. ABGSCe, EBIT SEK 7.6m vs. ABGSCe 9.4m * Three coating products launched in Korea in Q4 * Sizeable customer with financial constraints impacting volumes Q4 results I-Tech reported sales of SEK 39m, falling 13% short of our estimate (-33...

I-tech
Selskabsmeddelelse5.2.2026, 07.00

I-Tech AB (publ) (ticker: ITECH) publish the year-end report for 2025

I-tech
Eksterne analyser29.1.2026, 08.48

I-tech: No easy lap into Q4e - ABG

* Q4e sales SEK 45m (58m), adj. EBIT SEK 10m (19m) * We cut '26e-'27e sales and EBIT by 10% and 22-19%, respectively * Lowered growth assumptions for CMP Tough comps in Q4e We estimate Q4 sales of SEK 45m, -23% y-o-y (-12% organic, -11% FX). I-Tech is...

I-tech
Selskabsmeddelelse17.12.2025, 15.30

Raouf Kattan resigns as a board member of I-Tech AB (publ)

I-tech
Eksterne analyser27.11.2025, 09.39

I-tech: Proposed non-renewal of Selektope in the EU - ABG

* European Commission drafts proposal for non-renewal of Selektope* Limited impact on near-term estimates, EU ~2% of total sales* Voting expected to occur some time in H1'26, final decision in mid-26European Commission drafts proposal for non-renewal...

I-tech
Selskabsmeddelelse27.11.2025, 07.45

I-Tech strongly rejects the European Commission’s proposed non-renewal of Medetomidine under the EU Biocidal Products Regulation (BPR)

I-tech